Press release
Smoking Cessation & Nicotine De-Addiction Product Market worth $53.87 billion by 2030, growing at a CAGR of 9.65% - Exclusive Report by 360iResearch
The "Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/smoking-cessation-nicotine-de-addiction-product?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Smoking cessation and nicotine de-addiction products encompass a variety of pharmaceutical and therapeutic offerings designed to support individuals in quitting smoking and overcoming nicotine dependency. These include Nicotine Replacement Therapies (NRTs) such as patches, gums, lozenges, inhalers, and nasal sprays, alongside prescription medications like Varenicline (Chantix) and Bupropion (Zyban), non-nicotine medications, and vaping products, which are sometimes considered for harm reduction. Additionally, behavioral treatments involving counseling, support groups, and telehealth services are integral components. The global necessity for these products is underscored by smoking as a prominent cause of preventable diseases such as cardiovascular and respiratory conditions, various cancers, and complications for pregnant women. The end-use scope spans healthcare institutions, retail and online pharmacies, rehabilitation centers, and public health campaigns. Key growth drivers include rising awareness of smoking-related health risks, governmental support, increasing healthcare costs prompting preventive care, and innovative cessation aids accessible through digital platforms. Emerging opportunities exist in digital platforms for virtual counseling, combination therapies, global market expansion, and non-invasive product innovation. However, challenges include product misuse, stringent regulations, market saturation, and compliance issues. Innovation areas with potential include integrating behavioral sciences with drug therapy, using pharmacogenomics to tailor treatments, and developing safer non-combustible nicotine delivery methods. The market is characterized by high demand driven by public health initiatives, rapid innovation cycles, regulatory influences, and a growing preference for personalized, minimally invasive treatments. Companies are expected to focus on innovation, personalized treatments, and leveraging digital health trends while navigating regulatory landscapes and committing to extensive research and development to meet the evolving needs of those seeking to overcome nicotine addiction.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/smoking-cessation-nicotine-de-addiction-product?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
Based on Distribution, market is studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include Imperial Tobacco Company of India Limited, Philip Morris International Inc., Alkalon A/S, Japan Tobacco Inc., Strides Pharma Science Limited, Sparsha Pharma International Pvt. Ltd., GlaxoSmithKline PLC, Perrigo Company PLC, Pierre Fabre S.A., Enorama Pharma AB, Glenmark Pharmaceuticals Limited, Novartis International AG, JUUL Labs, Inc., Dr. Reddy's Laboratories Limited, Samyang Holdings Corporation, Rusan Pharma Ltd., 22nd Century Group, Inc., Pfizer Inc., Axsome Therapeutics, Inc., Ditch Labs, Cipla Ltd., Itaconix, British American Tobacco PLC, and Johnson & Johnson.
Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Smoking Cessation & Nicotine De-Addiction Product Market
We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Smoking Cessation & Nicotine De-Addiction Product Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Smoking Cessation & Nicotine De-Addiction Product Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.
Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/smoking-cessation-nicotine-de-addiction-product?utm_source=openpr&utm_medium=referral&utm_campaign=research-ai
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
8. Americas Smoking Cessation & Nicotine De-Addiction Product Market
9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
11. Competitive Landscape
12. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/smoking-cessation-nicotine-de-addiction-product?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smoking Cessation & Nicotine De-Addiction Product Market worth $53.87 billion by 2030, growing at a CAGR of 9.65% - Exclusive Report by 360iResearch here
News-ID: 3598426 • Views: …
More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…

The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…

The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…

The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Nicotine
Oral Nicotine Products Market Is Booming So Rapidly | Major Giants Nicotine Pouc …
HTF MI recently introduced Global Oral Nicotine Products Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Oral Nicotine Products Market are: Swedish Match (Sweden), Altria (USA), British American Tobacco (UK), Philip Morris International (USA/Switzerland),…
Nicotine and Nicotine Salts Market | Exploring Current Trends and Growth Status …
Nicotine and Nicotine Salts Market Outlook and Investment Analysis
What is the current outlook of the Nicotine and Nicotine Salts market?
The Nicotine and Nicotine Salts market is experiencing rapid growth driven by rising consumer demand for e-cigarettes and other nicotine delivery systems. Increasing awareness about smoking cessation products, along with the shift towards less harmful alternatives like vaping, has contributed to the market's expansion. The rising trend of e-cigarette usage, particularly…
Nicotine Gum Market: A Comprehensive Overview
The Global Nicotine Gum Market was valued at approximately USD 1.63 billion in 2023 and is projected to reach around USD 2.55 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2032.
Nicotine Gum Market Overview
The nicotine gum market is experiencing steady growth, primarily driven by increasing health awareness and the rising prevalence of smoking-related illnesses. As more individuals seek effective smoking cessation…
Sofi Surge Zero Nicotine: A Revolutionary Leap in Nicotine-Free Vaping
[Tustin, 09.12.2024] - The vaping industry is transformed once again with the introduction of the Sofi Surge Zero Nicotine, a cutting-edge disposable device designed for those seeking a nicotine-free vaping experience. This innovative product is poised to make waves among vapers who desire the pleasure of vaping without the addictive component of nicotine, while still enjoying unmatched flavor and convenience.
With a remarkable 25,000 puff capacity, the Sofi Surge Zero Nicotine…
Global Nicotine Market Research Report
This report studies the global Nicotine market status and forecast, categorizes the global Nicotine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Alchem International Siegfried CAMBREX CHARLES CITY FERTIN PHARMA JOHNSON AND JOHNSON CONSUMER INC Laboratorios Haymann Mallinckrodt Pharmaceuticals PORTON FINE…
Global Nicotine Polacrilex Market Research Report
This report studies the global Nicotine Polacrilex market status and forecast, categorizes the global Nicotine Polacrilex market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report BGP HEALTHCARE Cambrex Corporate Nicobrand Alchem International DIXIE CHEMICAL FERTIN PHARMA Laboratorios Haymann MALLINCKRODT NICOBRAND PORTON FINE…